EW
SHOW DAILY
48
in the laser vision correction space.
Dr. Schallhorn will share data on
another large Optical Express study,
in
which he analyzed 8,905 eyes
(4,721 patients) with low-to-moder-
ate myopia that underwent LASIK
with the iDesign (Abbott Medical
Optics, AMO, Santa Ana, Calif.)
in the U.K. and retrospectively com-
pared results to 27,290 matched eyes
(14,589 patients) that underwent
LASIK with the WaveScan (AMO).
Overall,
Dr. Schallhorn will address
the remarkable results with
advanced wavefront technology:
84% of eyes achieving 20/16 UCVA
one month postop.
Dr. Schallhorn will share poten-
tial benefits that topography-guided
ablations may bring to a refractive
practice.
Topography-guided LASIK
was recently approved by the FDA
with promising results on virgin
eyes. What is particularly encourag-
ing is the high patient satisfaction,
with 98% of patients saying they
would undergo the procedure again
three months postop.
Jason
Brinton, MD, will
advance the discussion further with
questioning the 20/20 benchmark
commonly used for refractive suc-
cess. He will propose why 20/20
UCVA simply isn't good enough
anymore, and physicians need to
strive for a new consistent, practical
measure for refractive success. Such
metrics
could include speed of visual
recovery and patient satisfaction:
• How fast can patients return to
normal activity?
• Do patients still have to bring a
driver?
• What about halos, glare, and dry
eye?
• What do patients think about
their
results?
• Are patient satisfied with their
care?
• How likely are patients to refer?
Dr. Brinton suggests that all
technology advancements are lead-
ing us to be able to go beyond the
20/20 UCVA threshold, and encour-
ages ophthalmologists to achieve a
new level of patient satisfaction and
outcomes going forward. The bar
must be raised in order to grow
refractive surgery: It will now take
an extra 33 happy patients to
overcome one unhappy patient.
Gustavo Tamayo, MD, will
round out the discussion of new
technology improving outcomes
with a comprehensive examination
of femtosecond arcuates versus
manual incisions. Consistency of
shape, depth, and overall effective-
ness must be considered when
analyzing laser compared to manual.
Dr. Tamayo will share data to show
why femtosecond arcuates may be a
more predictable way to manage
astigmatism, for the customization,
repeatability as well as the ability to
go intrastromal. Dr. Tamayo will
address why this technology leads us
to more of an exact science to meet
modern refractive needs.
This CME Education symposium
is supported by an unrestricted
educational grant from Abbott
Medical Optics.
EW
Saturday, April 26, 2014
Meeting Reporter
Sunday
symposium continued from page 47
